We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

Zivo Bioscience Inc (ZIVO) USD0.001

Sell:$4.10 Buy:$4.30 Change: $0.055 (1.34%)
Market closed |  Prices as at close on 5 July 2022 | Switch to live prices |
Change: $0.055 (1.34%)
Market closed |  Prices as at close on 5 July 2022 | Switch to live prices |
Change: $0.055 (1.34%)
Market closed |  Prices as at close on 5 July 2022 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Zivo Bioscience, Inc. is a research and development company. The Company is engaged in developing bioactive compounds derived from its algal culture, targeting human and animal diseases, such as poultry coccidiosis, bovine mastitis, human cholesterol, and canine osteoarthritis. Its algal biomass contains vitamin A, protein, iron, fatty acids, non-starch polysaccharides and other micronutrients. Its products include Poultry Gut Health, Bovine Mastitis, Canine Joint Health, Human Immune Modulation, Algal biomass for human consumption, Algal biomass for animal feed and Biomass for supporting skin health / anti-aging. The Company is also engaged in licensing and selling natural bioactive ingredients derived from their algae cultures to animal, human and dietary supplement and medical food manufacturers.

Contact details

21 E. Long Lake Road, Suite 100
United States
+1 (248) 4529866

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
$38.67 million
Shares in issue:
9.42 million
Personal Products
United States
US dollar

Key personnel

  • John Payne
    Chairman of the Board, President, Chief Executive Office, Director
  • Keith Marchiando
    Chief Financial Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.